NasdaqGS:MEDPLife Sciences
Can Medpace Holdings (MEDP) Justify Its Valuation On Backlog Quality Concerns?
Recent commentary on Medpace Holdings (MEDP) focuses less on headline growth and more on the composition of its $2.93b backlog, as shifting cancellation patterns reshape how investors view its revenue visibility.
See our latest analysis for Medpace Holdings.
Medpace Holdings' recent share price has been volatile, with the stock falling 3.33% on the day to $546.29 but showing a 20.26% 1 month share price return. The 1 year total shareholder return of 69.39% and 5 year total shareholder return...